Published : 1 February, 2025
In this article, Mr. D.S. Negi, CEO of Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), highlights the transformative advancements in cancer care, from AI-driven diagnostics to telesurgery. In 2024, key breakthroughs included India’s first indigenous CAR T-cell therapy, enhanced HPV immunization, and innovations in childhood cancer treatment. Government initiatives like reduced medicine costs and infrastructure upgrades aim to enhance accessibility. Looking ahead, 2025 promises advancements in precision medicine, AI integration, and expanded CAR T-cell applications. With increased healthcare spending, India is moving towards a future where cancer care is not just advanced but also preventive and affordable, ensuring better outcomes for patients.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE